Showing results (421-430 of 8,938) with videos related to
Sort By:
Pageof 894
Journal of Cancer Research and Clinical Oncology|November 10, 2009
Analysis of the expression of hyaluronan in intraductal and invasive carcinomas of the breastMaria Daniela Corte, Luis Ovidio González, Sara Junquera, et al.Journal of Cancer Research and Clinical Oncology|November 10, 2009
Features of senescence and cell death induced by doxorubicin in A549 cells: organization and level of selected cytoskeletal proteinsAnna Litwiniec, Alina Grzanka, Anna Helmin-Basa, et al.Journal of Cancer Research and Clinical Oncology|November 17, 2009
Macrophage migration inhibitory factor expression in cervical cancerMathias Krockenberger, Jörg B Engel, Julia Kolb, et al.Journal of Cancer Research and Clinical Oncology|November 17, 2009
Expression of IL-13Ralpha2 in liver cancer cells and its effect on targeted therapy of liver cancerLingling Hou, Juan Du, Jianwei Wang, et al.Journal of Cancer Research and Clinical Oncology|December 17, 2009
Gene-environment interactions associated with CYP1A1 MspI and GST polymorphisms and the risk of upper aerodigestive tract cancers in an Indian populationSoya Sisy Sam, Vinod Thomas, K S Reddy, et al.Journal of Cancer Research and Clinical Oncology|December 17, 2009
The role of surgery in clinical management of patients with metastatic papillary renal cell carcinomaThomas Steiner, Hartmut Kirchner, Michael Siebels, et al.Journal of Cancer Research and Clinical Oncology|November 12, 2005
Solitary fibrous tumor in the thigh: review of the literatureJ O Anders, M Aurich, T Lang, et al.Journal of Cancer Research and Clinical Oncology|November 12, 2005
Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell linesMegumi Senju, Naoko Sueoka, Akemi Sato, et al.Journal of Cancer Research and Clinical Oncology|November 18, 2005
MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patientsLinnea M Baudhuin, Lewis R Roberts, Felicity T B Enders, et al.Journal of Cancer Research and Clinical Oncology|November 18, 2005
Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapyT Lissitchkov, G Arnaudov, D Peytchev, et al.Pageof 894